Logo image of MNST

MONSTER BEVERAGE CORP (MNST) Stock Fundamental Analysis

USA - NASDAQ:MNST - US61174X1090 - Common Stock

68.73 USD
+0.58 (+0.85%)
Last: 10/8/2025, 8:01:55 PM
68.71 USD
-0.02 (-0.03%)
Pre-Market: 10/9/2025, 6:02:58 AM
Fundamental Rating

6

Overall MNST gets a fundamental rating of 6 out of 10. We evaluated MNST against 33 industry peers in the Beverages industry. MNST has outstanding health and profitabily ratings, belonging to the best of the industry. This is a solid base for any company. MNST is valied quite expensively at the moment, while it does show a decent growth rate. This makes MNST very considerable for quality investing!


Dividend Valuation Growth Profitability Health

Quickly go to:

8

1. Profitability

1.1 Basic Checks

In the past year MNST was profitable.
In the past year MNST had a positive cash flow from operations.
In the past 5 years MNST has always been profitable.
In the past 5 years MNST always reported a positive cash flow from operatings.
MNST Yearly Net Income VS EBIT VS OCF VS FCFMNST Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 500M 1B 1.5B 2B

1.2 Ratios

The Return On Assets of MNST (18.02%) is better than 96.97% of its industry peers.
MNST has a better Return On Equity (21.88%) than 81.82% of its industry peers.
MNST has a better Return On Invested Capital (22.67%) than 96.97% of its industry peers.
Measured over the past 3 years, the Average Return On Invested Capital for MNST is significantly above the industry average of 10.78%.
The 3 year average ROIC (19.65%) for MNST is below the current ROIC(22.67%), indicating increased profibility in the last year.
Industry RankSector Rank
ROA 18.02%
ROE 21.88%
ROIC 22.67%
ROA(3y)16.92%
ROA(5y)18.23%
ROE(3y)20.7%
ROE(5y)22.08%
ROIC(3y)19.65%
ROIC(5y)20.53%
MNST Yearly ROA, ROE, ROICMNST Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5 10 15 20 25

1.3 Margins

With an excellent Profit Margin value of 20.54%, MNST belongs to the best of the industry, outperforming 90.91% of the companies in the same industry.
In the last couple of years the Profit Margin of MNST has declined.
MNST's Operating Margin of 28.59% is amongst the best of the industry. MNST outperforms 87.88% of its industry peers.
MNST's Operating Margin has declined in the last couple of years.
MNST has a better Gross Margin (55.18%) than 75.76% of its industry peers.
In the last couple of years the Gross Margin of MNST has declined.
Industry RankSector Rank
OM 28.59%
PM (TTM) 20.54%
GM 55.18%
OM growth 3Y-5.5%
OM growth 5Y-3.99%
PM growth 3Y-6.78%
PM growth 5Y-5.25%
GM growth 3Y-1.24%
GM growth 5Y-1.56%
MNST Yearly Profit, Operating, Gross MarginsMNST Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20 40 60

More info and screens

9

2. Health

2.1 Basic Checks

MNST has a Return on Invested Capital (ROIC), which is well above the Cost of Capital (WACC), which means it is creating value.
MNST has less shares outstanding than it did 1 year ago.
The number of shares outstanding for MNST has been reduced compared to 5 years ago.
Compared to 1 year ago, MNST has a worse debt to assets ratio.
MNST Yearly Shares OutstandingMNST Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M 1B
MNST Yearly Total Debt VS Total AssetsMNST Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2B 4B 6B 8B

2.2 Solvency

An Altman-Z score of 29.66 indicates that MNST is not in any danger for bankruptcy at the moment.
With an excellent Altman-Z score value of 29.66, MNST belongs to the best of the industry, outperforming 100.00% of the companies in the same industry.
MNST has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0
Altman-Z 29.66
ROIC/WACC2.58
WACC8.78%
MNST Yearly LT Debt VS Equity VS FCFMNST Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2B 4B 6B 8B

2.3 Liquidity

A Current Ratio of 3.52 indicates that MNST has no problem at all paying its short term obligations.
Looking at the Current ratio, with a value of 3.52, MNST belongs to the top of the industry, outperforming 93.94% of the companies in the same industry.
A Quick Ratio of 3.00 indicates that MNST has no problem at all paying its short term obligations.
Looking at the Quick ratio, with a value of 3.00, MNST belongs to the top of the industry, outperforming 100.00% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 3.52
Quick Ratio 3
MNST Yearly Current Assets VS Current LiabilitesMNST Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 1B 2B 3B 4B 5B

More info and screens

5

3. Growth

3.1 Past

MNST shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 8.64%, which is quite good.
The Earnings Per Share has been decreasing by -4.72% on average over the past years.
MNST shows a small growth in Revenue. In the last year, the Revenue has grown by 3.70%.
MNST shows quite a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 12.27% yearly.
EPS 1Y (TTM)8.64%
EPS 3Y-10.82%
EPS 5Y-4.72%
EPS Q2Q%24.39%
Revenue 1Y (TTM)3.7%
Revenue growth 3Y10.58%
Revenue growth 5Y12.27%
Sales Q2Q%11.1%

3.2 Future

MNST is expected to show quite a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 14.75% yearly.
Based on estimates for the next years, MNST will show a quite strong growth in Revenue. The Revenue will grow by 8.32% on average per year.
EPS Next Y20.83%
EPS Next 2Y16.45%
EPS Next 3Y13.96%
EPS Next 5Y14.75%
Revenue Next Year7.8%
Revenue Next 2Y8.11%
Revenue Next 3Y7.69%
Revenue Next 5Y8.32%

3.3 Evolution

When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
MNST Yearly Revenue VS EstimatesMNST Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2016 2018 2020 2022 2024 2026 2028 2030 2032 2B 4B 6B 8B 10B
MNST Yearly EPS VS EstimatesMNST Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2016 2018 2020 2022 2024 2026 2028 2030 2032 1 2 3 4

More info and screens

2

4. Valuation

4.1 Price/Earnings Ratio

A Price/Earnings ratio of 39.05 indicates a quite expensive valuation of MNST.
Compared to the rest of the industry, the Price/Earnings ratio of MNST indicates a slightly more expensive valuation: MNST is more expensive than 60.61% of the companies listed in the same industry.
The average S&P500 Price/Earnings ratio is at 27.91. MNST is valued slightly more expensive when compared to this.
MNST is valuated quite expensively with a Price/Forward Earnings ratio of 31.48.
Based on the Price/Forward Earnings ratio, MNST is valued a bit more expensive than 60.61% of the companies in the same industry.
The average S&P500 Price/Forward Earnings ratio is at 23.30. MNST is valued slightly more expensive when compared to this.
Industry RankSector Rank
PE 39.05
Fwd PE 31.48
MNST Price Earnings VS Forward Price EarningsMNST Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30

4.2 Price Multiples

Based on the Enterprise Value to EBITDA ratio, MNST is valued a bit more expensive than 63.64% of the companies in the same industry.
Compared to the rest of the industry, the Price/Free Cash Flow ratio of MNST is on the same level as its industry peers.
Industry RankSector Rank
P/FCF 36.18
EV/EBITDA 28.43
MNST Per share dataMNST EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 2 4 6

4.3 Compensation for Growth

The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates an expensive valuation of the company.
The excellent profitability rating of MNST may justify a higher PE ratio.
MNST's earnings are expected to grow with 13.96% in the coming years. This may justify a more expensive valuation.
PEG (NY)1.87
PEG (5Y)N/A
EPS Next 2Y16.45%
EPS Next 3Y13.96%

More info and screens

0

5. Dividend

5.1 Amount

MNST does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

MONSTER BEVERAGE CORP

NASDAQ:MNST (10/8/2025, 8:01:55 PM)

Premarket: 68.71 -0.02 (-0.03%)

68.73

+0.58 (+0.85%)

Chartmill FA Rating
GICS SectorConsumer Staples
GICS IndustryGroupFood, Beverage & Tobacco
GICS IndustryBeverages
Earnings (Last)08-07 2025-08-07/amc
Earnings (Next)10-30 2025-10-30/amc
Inst Owners68.78%
Inst Owner Change0%
Ins Owners0.49%
Ins Owner Change-0.36%
Market Cap67.11B
Analysts76
Price Target67.84 (-1.29%)
Short Float %2.77%
Short Ratio3.37
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)1.94%
Min EPS beat(2)-0.21%
Max EPS beat(2)4.08%
EPS beat(4)1
Avg EPS beat(4)-2.85%
Min EPS beat(4)-8.27%
Max EPS beat(4)4.08%
EPS beat(8)2
Avg EPS beat(8)-3.63%
EPS beat(12)3
Avg EPS beat(12)-2.74%
EPS beat(16)3
Avg EPS beat(16)-5.18%
Revenue beat(2)0
Avg Revenue beat(2)-4.34%
Min Revenue beat(2)-8.24%
Max Revenue beat(2)-0.44%
Revenue beat(4)0
Avg Revenue beat(4)-3.28%
Min Revenue beat(4)-8.24%
Max Revenue beat(4)-0.44%
Revenue beat(8)0
Avg Revenue beat(8)-3.56%
Revenue beat(12)0
Avg Revenue beat(12)-3.65%
Revenue beat(16)3
Avg Revenue beat(16)-2.15%
PT rev (1m)0.2%
PT rev (3m)6.79%
EPS NQ rev (1m)0.04%
EPS NQ rev (3m)4.62%
EPS NY rev (1m)0.08%
EPS NY rev (3m)2.66%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)3.46%
Revenue NY rev (1m)-0.11%
Revenue NY rev (3m)1.53%
Valuation
Industry RankSector Rank
PE 39.05
Fwd PE 31.48
P/S 8.76
P/FCF 36.18
P/OCF 32.68
P/B 9.33
P/tB 15.11
EV/EBITDA 28.43
EPS(TTM)1.76
EY2.56%
EPS(NY)2.18
Fwd EY3.18%
FCF(TTM)1.9
FCFY2.76%
OCF(TTM)2.1
OCFY3.06%
SpS7.84
BVpS7.36
TBVpS4.55
PEG (NY)1.87
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 18.02%
ROE 21.88%
ROCE 29.31%
ROIC 22.67%
ROICexc 31.37%
ROICexgc 63.95%
OM 28.59%
PM (TTM) 20.54%
GM 55.18%
FCFM 24.22%
ROA(3y)16.92%
ROA(5y)18.23%
ROE(3y)20.7%
ROE(5y)22.08%
ROIC(3y)19.65%
ROIC(5y)20.53%
ROICexc(3y)29.02%
ROICexc(5y)32.32%
ROICexgc(3y)64.44%
ROICexgc(5y)84.58%
ROCE(3y)25.4%
ROCE(5y)26.54%
ROICexcg growth 3Y-12.83%
ROICexcg growth 5Y-13.62%
ROICexc growth 3Y-5.49%
ROICexc growth 5Y-2.02%
OM growth 3Y-5.5%
OM growth 5Y-3.99%
PM growth 3Y-6.78%
PM growth 5Y-5.25%
GM growth 3Y-1.24%
GM growth 5Y-1.56%
F-Score7
Asset Turnover0.88
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0
Debt/EBITDA 0
Cap/Depr 213.85%
Cap/Sales 2.59%
Interest Coverage 75.62
Cash Conversion 89.98%
Profit Quality 117.9%
Current Ratio 3.52
Quick Ratio 3
Altman-Z 29.66
F-Score7
WACC8.78%
ROIC/WACC2.58
Cap/Depr(3y)319.34%
Cap/Depr(5y)225.06%
Cap/Sales(3y)3.21%
Cap/Sales(5y)2.29%
Profit Quality(3y)86.9%
Profit Quality(5y)86.95%
High Growth Momentum
Growth
EPS 1Y (TTM)8.64%
EPS 3Y-10.82%
EPS 5Y-4.72%
EPS Q2Q%24.39%
EPS Next Y20.83%
EPS Next 2Y16.45%
EPS Next 3Y13.96%
EPS Next 5Y14.75%
Revenue 1Y (TTM)3.7%
Revenue growth 3Y10.58%
Revenue growth 5Y12.27%
Sales Q2Q%11.1%
Revenue Next Year7.8%
Revenue Next 2Y8.11%
Revenue Next 3Y7.69%
Revenue Next 5Y8.32%
EBIT growth 1Y8.74%
EBIT growth 3Y4.5%
EBIT growth 5Y7.79%
EBIT Next Year19.03%
EBIT Next 3Y11.94%
EBIT Next 5Y11.93%
FCF growth 1Y37.56%
FCF growth 3Y14.4%
FCF growth 5Y10.46%
OCF growth 1Y35.1%
OCF growth 3Y18.61%
OCF growth 5Y11.61%